CDG Invest Growth invests in the capital of companies in Morocco and Africa

CDG Invest Growth exits Techniques Science-Santé (T2S)

14 décembre 2021

CDG Invest Growth announces the completion of its exit from Techniques Science-Santé (T2S) through a sale to a holding company owned by Helios investment fund.

CDG Invest Growth acquired a significant minority stake in T2S  in June 2016 through the Capmezzanine II fund.

Founded in 1992 by Mr. Abderraouf Sordo and his four partners, T2S has become, in less than three decades, the undisputed leader in the distribution and maintenance of medical equipment in Morocco and then in French-speaking Africa, with revenues of around 700 Mdhs in 2020. T2S’s success is the result of long-standing relationships with leading medical device manufacturers, as well as the trust and legitimacy it enjoys with its customers.

Click here for more information about T2S

CDG Invest Growth, the leading growth equity investor in Morocco invested in Group Oncorad, a private healthcare provider focused on oncology and radiology. Oncorad was founded in 1999 by Pr. Redouane Samlali and Dr. Omar Hajji.  Their first center was Clinique le Littoral which opened in 2000 in Casablanca. Through the years, Clinique le Littoral […]

CDG Invest Growth takes a stake in Maymana, a leading company operating in bakery, pastry, fine stores and high-end catering. Maymana, a major bakery, pastry, fine grocery and high-end catering company Founded in 1985 by Mrs. Naima Berrada Benchakroun with the ambition to help empower women in Morocco, Maymana is today a major high-end catering […]

29 July 2021 CDG Invest Growth (“CIG”), the leading Morocco based private equity firm previously known as CDG Capital Private Equity, and Techniques Science-Santé (“T2S”), IM Alliance, Cyclopharma and Binarios (together, the “Company” or the “Group”) are pleased to announce the signing of an agreement for the sale of a majority stake in the largest […]